125 related articles for article (PubMed ID: 1849810)
1. The acute and chronic antihypertensive effects of ketanserin cannot be explained by blockade of vascular serotonin, type 2, receptors or alpha 1-adrenergic receptors.
Blauw GJ; van Brummelen P; Doorenbos CJ; van der Velde EA; van Zwieten PA
Clin Pharmacol Ther; 1991 Apr; 49(4):377-84. PubMed ID: 1849810
[TBL] [Abstract][Full Text] [Related]
2. Regional vascular effects of serotonin and ketanserin in young, healthy subjects.
Blauw GJ; van Brummelen P; Chang PC; Vermeij P; van Zwieten PA
Hypertension; 1988 Mar; 11(3):256-63. PubMed ID: 2832328
[TBL] [Abstract][Full Text] [Related]
3. Local hemodynamic effects of serotonin and ketanserin in healthy subjects: studies in the forearm.
Blauw GJ; van Brummelen P; Bruning T; van Zwieten PA
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S41-3. PubMed ID: 2459513
[TBL] [Abstract][Full Text] [Related]
4. Can peripheral serotonergic blockade explain the hypotensive effect of ketanserin?
Vanhoutte PM
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S105-9. PubMed ID: 2412025
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive effects of ketanserin and ritanserin in the spontaneously hypertensive rat.
Persson B; Gradin K; Pettersson A; Hedner T
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S22-4. PubMed ID: 2459509
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of ketanserin in hypertension and vasospastic disease.
Wenting GJ; Brouwer RM; vd Meiracker AJ; Man in't Veld AJ; Schalekamp MA
Acta Cardiol; 1987; 42(5):339-54. PubMed ID: 2827406
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by intraventricular microinfusion of ketanserin of the cardiovascular responses to peripheral administration of methoxamine in rats.
Mollace V; De Francesco EA; Fersini G; Nisticò G
Funct Neurol; 1991; 6(2):101-6. PubMed ID: 1655588
[TBL] [Abstract][Full Text] [Related]
8. 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.
Wenting GJ; Woittiez AJ; Man in't Veld AJ; Schalekamp MA
Hypertension; 1984; 6(1):100-9. PubMed ID: 6319278
[TBL] [Abstract][Full Text] [Related]
9. [Effects of chronic antihypertensive treatment with ketanserin versus metoprolol on blood pressure and compliance of great arteries in man: a double-blind crossover study].
Crispino M
Ann Ital Med Int; 1990; 5(4 Pt 2):469-76. PubMed ID: 2102134
[TBL] [Abstract][Full Text] [Related]
10. Evidence that blood pressure reduction by serotonin antagonists is related to alpha receptor blockade in spontaneously hypertensive rats.
Cohen ML; Fuller RW; Kurz KD
Hypertension; 1983; 5(5):676-81. PubMed ID: 6311738
[TBL] [Abstract][Full Text] [Related]
11. Influence of calcium entry blockade on alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in the forearm of hypertensive patients.
Jie K; van Brummelen P; Vermey P; Timmermans PB; van Zwieten PA
Eur J Clin Pharmacol; 1987; 32(2):115-20. PubMed ID: 3034623
[TBL] [Abstract][Full Text] [Related]
12. Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin.
Vanhoutte P; Amery A; Birkenhäger W; Breckenridge A; Bühler F; Distler A; Dormandy J; Doyle A; Frohlich E; Hansson L
Hypertension; 1988 Feb; 11(2):111-33. PubMed ID: 3277910
[TBL] [Abstract][Full Text] [Related]
13. Effect of alpha adrenergic agonist on the rabbit ear artery contraction to serotonin: enhanced response mediated by serotonergic1-like receptors.
Movahedi H; Le HT; Spanggord HM; Purdy RE
J Pharmacol Exp Ther; 1995 Jan; 272(1):364-70. PubMed ID: 7815353
[TBL] [Abstract][Full Text] [Related]
14. [Effects of ketanserin on glucose metabolism in hypertensive diabetic subjects].
Carleo R; Gobbo M; Bonavita M; De Matteo A; Gallo M; Gatti A
Boll Soc Ital Biol Sper; 1990 Jul; 66(7):639-46. PubMed ID: 1964564
[TBL] [Abstract][Full Text] [Related]
15. Ketanserin: haemodynamic effects and mechanism of action.
Schalekamp MA; Woittiez AJ; Wenting GJ; van den Meiracker AH; Man in 't Veld AJ
J Hypertens Suppl; 1986 Apr; 4(1):S7-12. PubMed ID: 2871144
[TBL] [Abstract][Full Text] [Related]
16. Arterial and venous effects of serotonin in the forearm of healthy subjects are not age-related.
Blauw GJ; van Brummelen P; Chang PC; Vermeij P; van Zwieten PA
J Cardiovasc Pharmacol; 1989 Jul; 14(1):14-21. PubMed ID: 2475705
[TBL] [Abstract][Full Text] [Related]
17. Platelet deactivation by 5HT2-receptor blockade parallels the antihypertensive response to ketanserin.
Amstein R; Fetkovska N; Pletscher A; Bühler FR
J Hypertens; 1989 Apr; 7(4):255-60. PubMed ID: 2723427
[TBL] [Abstract][Full Text] [Related]
18. The alpha-adrenergic receptor blocking effect of ketanserin and the interaction between alpha-adrenergic and S2-serotonergic receptor blockade.
van der Starre PJ; Reneman RS
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S54-61. PubMed ID: 2459516
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of antihypertensive action of ketanserin in man.
Reimann IW; Frölich JC
Br Med J (Clin Res Ed); 1983 Aug; 287(6389):381-3. PubMed ID: 6135489
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive treatment with ketanserin shows no evidence of vascular serotonin2-receptor and alpha 1-adrenoceptor blockade.
Blauw GJ; Doorenbos CJ; Bruning TA; van Brummelen P; van Zwieten PA
Drugs; 1990; 40 Suppl 4():42-4. PubMed ID: 1982654
[No Abstract] [Full Text] [Related]
[Next] [New Search]
